Abigail Lewis, intern

New findings confirm TearCare's long-term effectiveness for dry eye disease, showing significant patient improvements with minimal treatments over 2 years.

The partnership marks a major step toward expanding global access to targeted treatments for this vision-threatening condition, according to a news release.